0001209191-23-017553.txt : 20230309
0001209191-23-017553.hdr.sgml : 20230309
20230309164739
ACCESSION NUMBER: 0001209191-23-017553
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230307
FILED AS OF DATE: 20230309
DATE AS OF CHANGE: 20230309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Loewen Andrea
CENTRAL INDEX KEY: 0001591100
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 23720369
MAIL ADDRESS:
STREET 1: C/O VITAL THERAPIES, INC.
STREET 2: 15010 AVENUE OF SCIENCE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
BUSINESS PHONE: 972-865-2219
MAIL ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-07
0
0001358762
REATA PHARMACEUTICALS INC
RETA
0001591100
Loewen Andrea
5320 LEGACY DRIVE
PLANO
TX
75024
0
1
0
0
SVP, Global Regulatory Affairs
Class A common stock
2023-03-07
4
M
0
15000
27.32
A
57793
D
Class A common stock
2023-03-07
4
S
0
17836
83.36
D
39957
D
Class A common stock
2023-03-07
4
S
0
1200
84.44
D
38757
D
Employee Stock Option (right to buy)
27.32
2023-03-07
4
M
0
15000
0.00
D
2032-01-03
Class A common stock
15000
35000
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $83.00 to $83.90. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $84.00 to $84.80. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The options began vesting in sixteen equal installments beginning on April 3, 2022. On February 28, 2023, based on the satisfaction of certain performance criteria, the options scheduled to vest on April 3, 2025, July 3, 2025, October 3, 2025, and January 3, 2026 vested immediately. The remainder of the vesting schedule will continue as originally stated, subject to continued service through each vesting date.
/s/ Tracy Herson, attorney-in-fact
2023-03-09